These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29759378)

  • 1. Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain.
    Leal KS; de Oliveira Silva MT; de Fátima Silva Rezende A; Bezerra FSB; Begnini K; Seixas F; Collares T; Dellagostin O; Portela RW; de Carvalho Azevedo VA; Borsuk S
    Vaccine; 2018 Jun; 36(25):3578-3583. PubMed ID: 29759378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
    Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium bovis BCG expressing the proteins CP40 or CP09720 of Corynebacterium pseudotuberculosis promotes protection in mice after challenge.
    de Pinho RB; Barbosa TN; Dall'Agno L; da Rocha Fonseca B; Bezerra FSB; Sousa FSS; Seixas FK; Collares T; Borsuk S
    Vaccine; 2024 Jan; 42(1):33-39. PubMed ID: 38044246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach for an immunogen against Corynebacterium pseudotuberculosis infection: An Escherichia coli bacterin expressing phospholipase D.
    Barros de Pinho R; de Oliveira Silva MT; Brenner G; Dié Alves MS; Azevedo V; Dias Portela R; Borsuk S
    Microb Pathog; 2021 Feb; 151():104746. PubMed ID: 33485993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge.
    Brum AA; Rezende AFS; Brilhante FS; Collares T; Begnine K; Seixas FK; Collares TV; Dellagostin OA; Azevedo V; Santos A; Portela RW; Borsuk S
    J Med Microbiol; 2017 May; 66(5):635-642. PubMed ID: 28516859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.
    Silva JW; Droppa-Almeida D; Borsuk S; Azevedo V; Portela RW; Miyoshi A; Rocha FS; Dorella FA; Vivas WL; Padilha FF; Hernández-Macedo ML; Lima-Verde IB
    BMC Vet Res; 2014 Dec; 10():965. PubMed ID: 25527190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.
    Hodgson AL; Tachedjian M; Corner LA; Radford AJ
    Infect Immun; 1994 Dec; 62(12):5275-80. PubMed ID: 7960105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
    Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
    Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of an ELISA test to detect antibodies in vaccinated sheep or infected Corynebacterium pseudotuberculosis].
    Solanet JJ; Malena R; Estein SM; Estevao Belchior S; Paolicchi FA
    Rev Argent Microbiol; 2011; 43(1):9-17. PubMed ID: 21491060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of Brazilian red propolis and recombinant protein rCP01850 in the immunoprophylaxis of Corynebacterium pseudotuberculosis infection in mice.
    Brilhante Bezerra FS; Silva Rezende AF; Oliveira Silva MT; Sena-Lopes Â; Roesch-Ely M; Pêgas Henriques JA; Padilha FF; Carvalho Azevedo VA; Dias Portela RW; Seixas FK; Collares TV; Savegnago L; Borsuk S
    Microb Pathog; 2020 Dec; 149():104354. PubMed ID: 32569789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
    Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A
    Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle.
    Hodgson AL; Krywult J; Corner LA; Rothel JS; Radford AJ
    Infect Immun; 1992 Jul; 60(7):2900-5. PubMed ID: 1612756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NanH and PknG putative virulence factors as a recombinant subunit immunogen against Corynebacterium pseudotuberculosis infection in mice.
    Thais de Oliveira Silva M; Barros de Pinho R; da Rocha Fonseca B; Silvestre Brilhante Bezerra F; Severo Sabedra Sousa F; Kommling Seixas F; Collares T; José Meyer Nascimento R; Wagner Portela R; Ariston Carvalho Azevedo V; Borsuk S
    Vaccine; 2020 Dec; 38(51):8099-8106. PubMed ID: 33190945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
    Droppa-Almeida D; Vivas WL; Silva KK; Rezende AF; Simionatto S; Meyer R; Lima-Verde IB; Delagostin O; Borsuk S; Padilha FF
    Vaccine; 2016 Feb; 34(8):1091-6. PubMed ID: 26796140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice.
    Bezerra FSB; Silva MTO; Rezende AFS; Lopes AS; de Pinho RB; Seixas FK; Collares TV; Portela RWD; Azevedo VAC; Borsuk S
    Vaccine; 2021 Apr; 39(18):2568-2574. PubMed ID: 33814234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin.
    Rizzi C; Peiter AC; Oliveira TL; Seixas AC; Leal KS; Hartwig DD; Seixas FK; Borsuk S; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2017 Feb; 112(2):123-130. PubMed ID: 28177046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.